RAINE CARTER: Open Payments
NPI 1548799240 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,630 in 109 payments from 36 companies in 2025. Trend: 2023 $2,281 · 2024 $2,297 · 2025 $2,630
Food & beverage: $2,630
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $324 |
| Genentech USA, Inc. | 14 | $273 |
| AstraZeneca Pharmaceuticals LP | 8 | $271 |
| Daiichi Sankyo Inc. | 6 | $155 |
| US Oncology Corporate, Inc. | 1 | $141 |
| PFIZER INC. | 6 | $111 |
| Tempus AI, Inc | 4 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $103 |
| GlaxoSmithKline, LLC. | 4 | $103 |
| Merck Sharp & Dohme LLC | 4 | $90 |
Products named: LYNPARZA, Polivy, RYBREVANT, TALVEY, XT CDX, Nubeqa, KEYTRUDA, DATROWAY.
Industry payments across LA — which companies pay providers there.
